GLP 1 Drugs May Lower Surgical Complications in Diabetes Patients [diet pill endorsed by dr oz]

GLP 1 Drugs May Lower Surgical Complications in Diabetes Patients [diet pill endorsed by dr oz]

| 1h 28m 28s | Video has closed captioning.

#diabetes #surgicalcomplication #woundreopening #hospitalreadmission People with diabetes who were taking GLP-1 receptor agonist drugs such as tirzepatide and semaglutide had significantly lower rates of hospital readmission, wound re-opening and hematoma after surgery, according to a large study. The study, published online in advance of print in the Annals of Surgery, analyzed de-identified hospital records covering 74,425 surgical procedures in 21,772 patients with diabetes over a three-and-a-half-year period ending in July 2023. The investigators found that patients taking GLP-1 receptor agonists, had about a 12% lower risk of hospital readmission within a month of surgery, a 29% lower risk of wound re-opening within six months of surgery, and about a 56% lower risk of hematoma (a collection of blood in tissue caused by bleeding) at the surgery site, compared with patients who were not taking such medications. Check full updates on Medical Dialogues Also check out - Medical Dialogues Academy, a renowned academic wing of Medical Dialogues - India's premier health and news online portal, proudly presents this comprehensive course tailored for healthcare professionals eager to delve into the realm of medical journalism. 🔗 Enroll Today: 📚 Explore More With Us: 📌 Medical Content Writing: 📌 Certificate Course in Pharmaceutical Medico-Marketing: Join us on this enlightening journey and become a part of a community pushing the boundaries of healthcare communication and reporting. Get the latest medical and health news at medicaldialogues.in Follow us on Twitter: Facebook: Instagram: LinkedIn: Website: